ENTRADA THERAPEUTICS, INC. Current Liabilities
ENTRADA THERAPEUTICS, INC. (TRDA) had Current Liabilities of $21.37 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-05
- 2026-06-30: Liabilities, Current $21.37M.
- 2026-03-31: Liabilities, Current $19.20M.
- 2025-12-31: Liabilities, Current $24.45M.
- 2025-09-30: Liabilities, Current $24.02M.
| Period end | Liabilities, Current |
|---|---|
| 2026-06-30 | $21.37M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $19.20M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $24.45M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $24.02M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $19.80M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $18.43M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $39.48M 10-K · filed 2026-02-26 |
| 2024-09-30 | $70.60M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $85.81M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $173.94M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $158.80M 10-K · filed 2025-02-27 |
| 2023-09-30 | $165.43M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $125.94M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $147.59M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $21.97M 10-K · filed 2024-03-13 |
| 2022-09-30 | $21.55M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $18.08M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $15.43M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $6.72M 10-K · filed 2023-03-06 |
| 2021-09-30 | $7.16M 10-Q · filed 2021-12-09 |
| 2020-12-31 | $3.36M 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |